Ignite Creation Date:
2025-12-24 @ 11:46 PM
Ignite Modification Date:
2026-02-26 @ 12:42 AM
Study NCT ID:
NCT02848651
Status:
COMPLETED
Last Update Posted:
2020-04-28
First Post:
2016-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-14
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-26
First Submit QC Date:
None
Study First Post Date:
2016-07-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-15
Results First Submit QC Date:
None
Results First Post Date:
2020-04-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-15
Last Update Post Date:
2020-04-28
Last Update Post Date Type:
ACTUAL